✦ LIBER ✦

P-229 Phase II evaluation of low dose suramin as a modulator of paclitaxel/carboplatin (P/C) in non-small cell lung cancer (NSCLC) patients

✍ Scribed by Villalona-Calero, Miguel A.; Otterson, G.; Wientjes, G.; Murgo, A.; Jensen, R.; Yeh, T.; Chen, D.; Song, S.; Grever, M.; Au, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-572 Phase I–II trial of TLK286 (telcyt

✍ Seguist, L.; Fidias, P.; Temel, J.; Kennedy, E.; Ostler, P.; Rabin, M.; Huberman 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 328 KB

P-251 Randomized phase II trial of weekl

✍ Socinski, Mark A.; Hensing, Thomas A.; Escudero, Miluska; Tynan, Maureen; Baggst 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 340 KB

A phase II study of carboplatin and pacl

✍ Giorgio, Carmelo Giannitto; Pappalardo, Alessandro; Russo, Antonio; Giuffrida, D 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Phase III trial of paclitaxel (P), carbo

✍ Socinski, MA; Sandler, AB; Petit, RG; Steagall, A; Hanover, CK; Natale, RB; Mill 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 212 KB

P-621 Concurrent hyperfractionated radio

✍ Jeremic, B.; Milicic, B.; Radosavljevic-Asic, G. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 124 KB

P-580 Phase II study of biweekly paclita

✍ Takayama, K.; Ichiki, M.; Kawasaki, M.; Ninomiya, K.; Miyazaki, N.; Kuba, M.; Ha 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB